NETRC

Prescribing Medications via Telehealth: Overview and Key Considerations

Home Navigate Telehealth Prescribing Medications via Telehealth: Overview and Key Considerations

Telehealth 101


Telehealth Policy


Telehealth Clinical Settings & Specialties

Prescribing Medications via Telehealth: Overview and Key Considerations

Prescribing medications through telehealth involves evaluating a patient remotely - often through real-time video or audio communication - and issuing prescriptions based on clinical judgment. As telehealth becomes a permanent part of healthcare delivery, understanding the legal, clinical, and operational factors that govern remote prescribing is essential for healthcare systems and providers.

Telehealth prescribing is governed by a combination of federal law, state practice regulations, and clinical standards of care. Providers must comply with all applicable regulations when issuing prescriptions during or following telehealth encounters, including special rules for controlled substances and state requirements for prescriber licensure and patient evaluations.

Regulatory Framework and Legal Considerations

Federal Requirements

  • Controlled Substances and the Ryan Haight Act:
    The Ryan Haight Online Pharmacy Consumer Protection Act generally requires an in-person medical evaluation before prescribing controlled substances via the internet or telemedicine.
    During and after the COVID-19 public health emergency, the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have extended telemedicine prescribing flexibilities that allow qualified practitioners to prescribe controlled substances - including schedules II-V - via telehealth without a prior in-person visit, provided certain conditions are met. These federal telemedicine prescribing flexibilities are extended through at least December 31, 2026.
    Proposed DEA rules would establish special prescribing registrations and additional safeguards for remote prescribing of controlled substances, including requirements for Prescription Drug Monitoring Program (PDMP) checks and recordkeeping.
  • Standard of Care Requirements:
    Regardless of modality, prescriptions issued after a telehealth visit must adhere to the same clinical standards as those issued after in-person encounters - including documentation of diagnosis, appropriate clinical evaluation, and justification for the medication.

It is important to note that the DEA's prescribing rules apply nationwide and are separate from both state requirements, which may be more restrictive in some cases, and Medicare's mental health in-person visit requirement, which is tied to reimbursement. The DEA has previously issued targeted final rules related to buprenorphine prescribing and Veterans Affairs continuity of care, though implementation of those rules has been delayed and may be revisited in light of the new extension.

State Law and Licensure

  • State Practice Rules:
    Prescribers must be licensed in the state where the patient is located at the time of the telehealth encounter to legally prescribe medications in that state. Some states participate in Interstate Medical Licensure Compacts that can facilitate multi-state practice.
  • State Telehealth Prescribing Policies:
    Many states have specific statutes and professional board rules governing online prescribing, including requirements for synchronous (real-time) telehealth, limits on prescribing controlled substances, and limitations on prescriptions based solely on static questionnaires.

Operational and Clinical Considerations

1. Establishing a Valid Patient-Provider Relationship

Before a prescription can be appropriately written, providers must establish a legitimate medical relationship with the patient consistent with applicable standards of care. This typically includes:

  • A thorough clinical interview;
  • Review of medical history;
  • Appropriate examination via telehealth (or in person when required);
  • Documentation that supports the clinical decision to prescribe.

For example, some state guidance prohibits issuing prescriptions “based solely on an internet questionnaire” without an interactive clinical evaluation.

2. Telehealth and Controlled Substances

Prescribing controlled substances remotely presents unique challenges and risks, which regulators seek to balance with access goals:

  • PDMP Reviews: Clinicians often must check state Prescription Drug Monitoring Programs before prescribing controlled substances to mitigate risk of misuse, diversion, or inappropriate prescribing. Proposed federal regulations would expand these requirements.
  • Safety Protocols: Enhanced identity verification, secure documentation, and structured follow-up care are critical for safe controlled substance prescribing.

3. Electronic Prescribing for Controlled Substances (EPCS)

Many states require clinicians to use electronic prescribing systems for controlled substances to ensure traceability and reduce prescription fraud, which can affect telehealth workflows.

Specific Clinical Use Cases and Models

Below are examples of telehealth prescribing applications that illustrate how remote medication management is being used to expand access to care - particularly in rural and medically underserved regions, including programs relevant to or originating in the Northeast.

Opioid Use Disorder (OUD) Treatment

  • Tele-Buprenorphine and OUD Care:
    Telemedicine is increasingly used to provide medication-assisted treatment (MAT) for opioid use disorder, including remote assessment and prescribing of buprenorphine. Federal policy changes allow clinicians to initiate buprenorphine through audio-video telehealth without an initial in-person visit, expanding access for patients in areas with few local addiction treatment specialists.
  • Rural Care Models:
    Mobile telehealth units equipped with video technology and clinical support have been used to connect patients in rural regions to distant specialists for OUD care, with telemedicine allowing prescribing and follow-up for buprenorphine treatment.
  • Example Northeast Provider:
    Bicycle Health, a Boston-based telehealth company, provides virtual opioid use disorder treatment - including remote medication management - across multiple states, illustrating a regional model of expanding access to pharmacotherapy through telehealth.

Chronic Disease Management

Telehealth prescribing is also used to manage chronic conditions such as hypertension, diabetes, and asthma. While these medications are generally non-controlled substances, remote prescribing helps expand ongoing medication management, particularly when integrated with remote monitoring devices and clinical follow-up pathways that improve adherence and outcomes.

Challenges and Risks in Telehealth Prescribing

Despite clear benefits, telehealth prescribing poses clinical, regulatory, and operational challenges:

Clinical Quality and Continuity

  • Ensuring that remote encounters include sufficient clinical evaluation to justify medication decisions;
  • Integrating telehealth records with broader medical records to support continuity of care;
  • Exchanging information with pharmacies and supervising ongoing therapy.

Regulatory Uncertainty

  • The evolving regulatory landscape - including temporary federal telemedicine prescribing flexibilities and proposed DEA special registrations - creates planning challenges for providers and healthcare systems. Ongoing policy developments may alter requirements for in-person evaluations or controlled substance prescribing in the future.

Interstate Practice Considerations

  • Telehealth prescribers must navigate state licensure and scope-of-practice laws for each state where patients are located. Licensure compact participation and dedicated telemedicine registrations can facilitate but not eliminate this complexity.

Risk of Inappropriate Prescribing and Oversight

Although limited, some telehealth prescribing models have drawn scrutiny for pressure-to-prescribe dynamics or partnerships that potentially encourage medication overuse without comprehensive evaluation, raising ethical and legal concerns. Regulatory enforcement has addressed inappropriate prescribing and payment incentives in telehealth contexts to protect patient safety.

Best Practices for Healthcare Organizations

Organizations implementing telehealth prescribing should:

  • Establish clear clinical protocols for telehealth assessments, documentation, medication justification, and follow-up;
  • Ensure compliance with federal controlled substance rules (including DEA telemedicine flexibilities and PDMP checks);
  • Maintain state-specific licensure and scope-of-practice compliance for all jurisdictions served;
  • Use secure, integrated EHR and electronic prescribing systems to support documentation and prescription tracking;
  • Provide training for clinicians on telehealth-specific prescribing practices and regulatory requirements.

Looking Ahead

Telehealth prescribing continues to evolve with policy changes at the federal and state levels, which will shape how providers balance access, quality, safety, and regulatory compliance. For example, ongoing DEA rulemaking may create new registration pathways for remote prescribing of controlled medications, affecting how telehealth providers deliver pharmacotherapy in the future.

Healthcare organizations and policymakers should monitor developments, participate in advocacy through professional associations like the American Telemedicine Association and leverage regional and national resources like the Northeast Telehealth Resource Center and the Center for Connected Health Policy to stay updated on best practices in telehealth prescribing.

Key Resources

Need more guidance? Contact us